Literature DB >> 10588421

Obsessive-compulsive disorder in patients with first-episode schizophrenia.

M Poyurovsky1, C Fuchs, A Weizman.   

Abstract

OBJECTIVE: The aim of the present study was to determine the rate of obsessive-compulsive disorder (OCD) in patients with first-episode schizophrenia.
METHOD: Fifty patients consecutively hospitalized with first-episode psychosis who met DSM-IV criteria for schizophrenia spectrum disorders were assessed for OCD. The instruments used were the Structured Clinical Interview for DSM-IV, Schedule for the Assessment of Positive Symptoms (SAPS), Schedule for the Assessment of Negative Symptoms (SANS), and Yale-Brown Obsessive Compulsive Scale.
RESULTS: Seven (14%) of the 50 schizophrenic patients met DSM-IV criteria for OCD and scored significantly lower than schizophrenic patients without OCD on the formal thought disorder subscale of the SAPS and the flattened affect subscale of the SANS.
CONCLUSIONS: OCD is relatively frequent in patients with first-episode schizophrenia and may have a "protective" effect on some schizophrenic symptoms, at least in the early stages of the disease.

Entities:  

Mesh:

Year:  1999        PMID: 10588421     DOI: 10.1176/ajp.156.12.1998

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  32 in total

Review 1.  Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature.

Authors:  Trehani M Fonseka; Margaret A Richter; Daniel J Müller
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

Review 2.  The Epidemiology and Associated Phenomenology of Formal Thought Disorder: A Systematic Review.

Authors:  Eric Roche; Lisa Creed; Donagh MacMahon; Daria Brennan; Mary Clarke
Journal:  Schizophr Bull       Date:  2014-09-01       Impact factor: 9.306

3.  Interventions for obsessive compulsive symptoms in people with schizophrenia.

Authors:  Mohan Raj; Saeed Farooq
Journal:  Cochrane Database Syst Rev       Date:  2005

4.  Nonclinical obsessive-compulsive symptoms and executive functions in schizophrenia.

Authors:  Sheba R Kumbhani; Robert M Roth; Carrie L Kruck; Laura A Flashman; Thomas W McAllister
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2010       Impact factor: 2.198

5.  Evidence for inhibitory deficits in the prefrontal cortex in schizophrenia.

Authors:  Natasha Radhu; Luis Garcia Dominguez; Faranak Farzan; Margaret A Richter; Mawahib O Semeralul; Robert Chen; Paul B Fitzgerald; Zafiris J Daskalakis
Journal:  Brain       Date:  2014-12-17       Impact factor: 13.501

6.  The 5-year course of obsessive-compulsive symptoms and obsessive-compulsive disorder in first-episode schizophrenia and related disorders.

Authors:  Lieuwe de Haan; Bouke Sterk; Luuk Wouters; Don H Linszen
Journal:  Schizophr Bull       Date:  2011-07-28       Impact factor: 9.306

Review 7.  How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association.

Authors:  Amélie M Achim; Michel Maziade; Eric Raymond; David Olivier; Chantal Mérette; Marc-André Roy
Journal:  Schizophr Bull       Date:  2009-12-03       Impact factor: 9.306

8.  Comparative Analysis of Cognitive Function in Schizophrenia with and without Obsessive Compulsive Disorder.

Authors:  Myung-Ji Lee; Yong-Bum Shin; Young-Kyung Sunwoo; Seung-Ho Jung; Won-Hyoung Kim; Min-Hee Kang; Jeong-Seop Lee; Jae-Nam Bae; Chul-Eung Kim
Journal:  Psychiatry Investig       Date:  2009-11-09       Impact factor: 2.505

9.  Insight into obsessive-compulsive symptoms and awareness of illness in adolescent schizophrenia patients with and without OCD.

Authors:  Sarit Faragian; Rena Kurs; Michael Poyurovsky
Journal:  Child Psychiatry Hum Dev       Date:  2007-06-13

10.  Stable cognitive deficits in schizophrenia patients with comorbid obsessive-compulsive symptoms: a 12-month longitudinal study.

Authors:  Frederike Schirmbeck; Franziska Rausch; Susanne Englisch; Sarah Eifler; Christine Esslinger; Andreas Meyer-Lindenberg; Mathias Zink
Journal:  Schizophr Bull       Date:  2012-10-27       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.